Page last updated: 2024-09-03

elacridar and Leukemia P388

elacridar has been researched along with Leukemia P388 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du Vignaud, P; Grand-Perret, T; Hyafil, F; Vergely, C	1

Other Studies

1 other study(ies) available for elacridar and Leukemia P388

Article	Year
In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer research, 1993, Oct-01, Volume: 53, Issue:19 Topics: Acridines; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Colonic Neoplasms; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Female; Humans; Isoquinolines; Leukemia P388; Mice; Mice, Inbred DBA; Ovary; Tetrahydroisoquinolines; Tumor Cells, Cultured	1993

Article

Year

In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

Cancer research, 1993, Oct-01, Volume: 53, Issue:19

Topics: Acridines; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Colonic Neoplasms; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Female; Humans; Isoquinolines; Leukemia P388; Mice; Mice, Inbred DBA; Ovary; Tetrahydroisoquinolines; Tumor Cells, Cultured

1993